252 related articles for article (PubMed ID: 1354161)
1. Combination of a delta opioid receptor agonist but not a mu opioid receptor agonist with the D1-selective dopamine receptor agonist SKF 38393 markedly potentiates different behaviors in mice.
Toyoshi T; Ukai M; Kameyama T
Eur J Pharmacol; 1992 Mar; 213(1):25-30. PubMed ID: 1354161
[TBL] [Abstract][Full Text] [Related]
2. [D-Ala2,NMePhe4,Gly-ol5]enkephalin, but not [D-Pen2,L-Pen5]enkephalin, specifically inhibits behaviors induced by the dopamine D2 agonist RU 24213.
Toyoshi T; Ukai M; Kameyama T
Eur J Pharmacol; 1991 Aug; 201(1):41-6. PubMed ID: 1686589
[TBL] [Abstract][Full Text] [Related]
3. Receptor-selective opioid peptides fail to affect behavioral responses induced by a low dose of apomorphine in the mouse.
Ukai M; Toyoshi T; Kameyama T
Pharmacol Biochem Behav; 1993 Nov; 46(3):587-91. PubMed ID: 7904071
[TBL] [Abstract][Full Text] [Related]
4. DAMGO ([D-Ala2,NMePhe4,Gly-ol]enkephalin), but not DPLPE ([D-Pen2,L- Pen5]enkephalin), specifically inhibits methamphetamine-induced behavioral responses in the mouse.
Ukai M; Toyoshi T; Kameyama T
Neuropharmacology; 1993 Oct; 32(10):1019-24. PubMed ID: 8295712
[TBL] [Abstract][Full Text] [Related]
5. Opioid peptides selective for receptor types modulate cocaine-induced behavioral responses in mice.
Ukai M; Mizutani M; Kameyama T
Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Jun; 14(3):153-9. PubMed ID: 7941780
[TBL] [Abstract][Full Text] [Related]
6. Differential modulation of behavioral responses by [D-Ala2, NMePhe4, Gly-ol]enkephalin, [D-Ala2] deltorphin II and [D-Pen2, L-Pen5]enkephalin in the mouse.
Ukai M; Toyoshi T; Mizutani M; Sasaki Y; Kameyama T
Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Jun; 14(3):161-8. PubMed ID: 7941781
[TBL] [Abstract][Full Text] [Related]
7. Effects of [D-Ala2, D-Leu5]enkephalin and [D-Pen2, L-Pen5]enkephalin on apomorphine-induced motor activity in the mouse.
Ukai M; Toyoshi T; Kameyama T
Pharmacol Biochem Behav; 1992 Jan; 41(1):171-6. PubMed ID: 1311454
[TBL] [Abstract][Full Text] [Related]
8. Intrastriatal injection of opioid receptor agonists inhibits apomorphine-induced behavior in 6-hydroxydopamine-treated mice.
Toyoshi T; Ukai M; Kameyama T
Eur J Pharmacol; 1995 Dec; 294(2-3):637-43. PubMed ID: 8750728
[TBL] [Abstract][Full Text] [Related]
9. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
Van Vliet BJ; Mulder AH; Schoffelmeer AN
J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
[TBL] [Abstract][Full Text] [Related]
10. Cocaine-like discriminative stimulus properties of the delta-selective opioid receptor agonist, [D-Pen2,L-Pen5]enkephalin, in the rat.
Ukai M; Mori E; Kameyama T
Eur J Pharmacol; 1993 Jan; 231(1):143-4. PubMed ID: 8383062
[TBL] [Abstract][Full Text] [Related]
11. Mesoaccumbens dopamine-opiate interactions in the control over behaviour by a conditioned reinforcer.
Phillips GD; Robbins TW; Everitt BJ
Psychopharmacology (Berl); 1994 Mar; 114(2):345-59. PubMed ID: 7838928
[TBL] [Abstract][Full Text] [Related]
12. Opioid receptor agonists selective for mu and kappa receptors attenuate methamphetamine-induced behavioral sensitization in the mouse.
Toyoshi T; Ukai M; Kameyama T
Biol Pharm Bull; 1996 Mar; 19(3):369-74. PubMed ID: 8924903
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of selective actions of dopamine D-1 and D-2 receptor agonists and antagonists on opioid antinociception.
Rooney KF; Sewell RD
Eur J Pharmacol; 1989 Sep; 168(3):329-36. PubMed ID: 2573534
[TBL] [Abstract][Full Text] [Related]
14. Blockade of D-2 dopamine receptors strongly enhances the potency of enkephalins to inhibit dopamine-sensitive adenylate cyclase in rat neostriatum: involvement of delta- and mu-opioid receptors.
Schoffelmeer AN; Hansen HA; Stoof JC; Mulder AH
J Neurosci; 1986 Aug; 6(8):2235-9. PubMed ID: 3018189
[TBL] [Abstract][Full Text] [Related]
15. Parametric and pharmacological analyses of the enhanced grooming response elicited by the D1 dopamine receptor agonist SKF 38393 in the rat.
Wachtel SR; Brooderson RJ; White FJ
Psychopharmacology (Berl); 1992; 109(1-2):41-8. PubMed ID: 1365670
[TBL] [Abstract][Full Text] [Related]
16. Multi-dimensional analysis of behavior in mice treated with the delta opioid agonists DADL (D-Ala2-D-Leu5-enkephalin) and DPLPE (D-Pen2-L-Pen5-enkephalin).
Ukai M; Toyoshi T; Kameyama T
Neuropharmacology; 1989 Oct; 28(10):1033-9. PubMed ID: 2554179
[TBL] [Abstract][Full Text] [Related]
17. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
Capasso A; Sorrentino L
Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
[TBL] [Abstract][Full Text] [Related]
18. The effects of dopamine D1 and D2 receptor antagonists on the rewarding effects of delta 1 and delta 2 opioid receptor agonists in mice.
Suzuki T; Tsuji M; Mori T; Misawa M; Nagase H
Psychopharmacology (Berl); 1996 Apr; 124(3):211-8. PubMed ID: 8740041
[TBL] [Abstract][Full Text] [Related]
19. DAGO ([D-Ala2,N-Me-Phe4,Gly-ol]enkephalin) specifically reverses apomorphine-induced increase in rearing and grooming behaviors in the mouse.
Ukai M; Toyoshi T; Kameyama T
Brain Res; 1991 Aug; 557(1-2):77-82. PubMed ID: 1660758
[TBL] [Abstract][Full Text] [Related]
20. Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penicillamine2-D-penicillamine5]enkephalin in the rat.
Drower EJ; Stapelfeld A; Rafferty MF; de Costa BR; Rice KC; Hammond DL
J Pharmacol Exp Ther; 1991 Nov; 259(2):725-31. PubMed ID: 1658309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
